Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Astrazeneca Plc (AZN)

Astrazeneca Plc (AZN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN PR Newswire - Thu Aug 6, 10:02PM CDT

NEW YORK , Aug. 6, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AstraZeneca PLC ("AstraZeneca" or the "Company") (NYSE: AZN). Such investors are advised to...

AZN : 158.83 (+0.05%)
Moderna Inc HQ-by hapabapa via iStock
MRNA Stock Gets a Shot in the Arm as FDA Approves Moderna Flu Vaccine Barchart - Thu Aug 6, 1:01PM CDT

Moderna has secured FDA approval for its flu vaccine mFLUSIVA. But does that warrant buying MRNA shares today? Let’s find out!

AZN : 158.83 (+0.05%)
MRNA : 63.74 (+5.23%)
RHHBY : 56.4000 (-0.39%)
PFE : 26.31 (-1.16%)
SOPHiA GENETICS Enters Collaboration to Develop Companion Diagnostics for Precision Oncology Therapies PR Newswire - Tue Aug 4, 5:15AM CDT

BOSTON and ROLLE, Switzerland , Aug. 4, 2026 /PRNewswire/ -- SOPHiA GENETICS  (NASDAQ: SOPH) today announced a new global collaboration to develop, validate, and deploy two companion diagnostics...

SOPH : 7.55 (-0.79%)
AZN : 158.83 (+0.05%)
Bristol Myers Squibb logo under a magnifying glass_ By Casimiro
The $400 Billion Reason Bristol-Myers Squibb (BMY) Stock Is Up Today Barchart - Mon Aug 3, 3:54PM CDT

Bristol-Myers stock extends gains on reports of a potential merger with AstraZeneca. But caution is warranted in chasing the momentum in BMY shares today.

AZN : 158.83 (+0.05%)
BMY : 63.83 (+0.35%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN PR Newswire - Thu Jul 30, 9:00AM CDT

NEW YORK , July 30, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AstraZeneca PLC ("AstraZeneca" or the "Company") (NYSE: AZN).  Such investors are advised...

AZN : 158.83 (+0.05%)
Sonesitatug vedotin demonstrated a statistically significant and highly clinically meaningful improvement in overall survival in 2nd and later-line CLDN18.2-positive advanced gastric/GEJ cancers Business Wire - Mon Jul 27, 6:05AM CDT

Results provide opportunity to expand CLDN18.2 positivity to ≥25% expression, representing approximately 60% of patients in this setting CLARITY-Gastric01...

AZN : 158.83 (+0.05%)
AZN.LN : 11,702.000 (-1.20%)
AstraZeneca results: H1 and Q2 2026 Business Wire - Mon Jul 27, 6:00AM CDT

Growth momentum continues. On track to deliver ambition of $80 billion in Total Revenue in 2030

AZN : 158.83 (+0.05%)
AZN.LN : 11,702.000 (-1.20%)
FOMC Out Next Week with Interest Rate Decision Baystreet - Sun Jul 26, 8:22PM CDT

Monday U.S. Economic Lookahead Durable-goods orders (June) Featured Earnings AstraZeneca ...

KLAC : 208.87 (+4.19%)
META : 580.73 (-3.07%)
AAPL : 301.58 (-1.09%)
KO : 87.06 (+0.67%)
CVX : 196.91 (+0.13%)
WELL : 229.37 (+1.87%)
ABBV : 247.95 (-0.86%)
MSFT : 492.18 (-2.31%)
MA : 559.32 (-0.38%)
AZN : 158.83 (+0.05%)
V : 359.74 (-0.85%)
XOM : 159.81 (+0.01%)
AstraZeneca's Monday Morning Call Will Reveal Whether Anyone Still Believes the Margin Math Barchart - Fri Jul 24, 4:01PM CDT

Barchart Research What to Expect from AZN Earnings AZN Generated July 24, 2026 Current Price $169.26 EPS Estimate $$2.50 Consensus Rating Strong Buy Average Move 2.07% AstraZeneca's Monday Morning Call...

AZN : 158.83 (+0.05%)
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of AstraZeneca PLC- AZN PR Newswire - Thu Jul 23, 9:00AM CDT

NEW YORK , July 23, 2026 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of AstraZeneca PLC ("AstraZeneca" or the "Company") (NYSE: AZN).  Such investors are advised...

AZN : 158.83 (+0.05%)

Barchart Exclusives

Unusual Put Volume in Rare Earth Stock REalloys Could Be a Bullish Play on ALOY Barchart - 31 minutes ago
Today's heavy options volume in rare-earth magnet company REalloys Inc. (ALOY) suggests that investors may be bullish on ALOY stock ahead of its earnings next week. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.